← Latest Filings

V

Venrock Healthcare Capital Partners III, L.P.

Open-market buys

12

$38.5M total

Open-market sells

5

$3.7M total

Tracking since

Mar 2026

Activity timeline

Open-market buy — $224K

Lycia Therapeutics, Inc. · Nov 2, 2026

Open-market buy — $5K

Lycia Therapeutics, Inc. · Oct 30, 2026

Open-market trades from the last two years.

Holdings as last reported

6,858,542 Common Stock in LYCA

Held indirectly (By Funds) · as of 2026-11-02

5,089,354 Common Stock in KALV

Held indirectly (By Funds) · as of 2026-03-26

Companies touched

Lycia Therapeutics, Inc.

KalVista Pharmaceuticals, Inc.